Image Description (180mcg Label)
This text provides detailed information about a medication called Pulmicort Flexhalerâ„¢ 180 meg, specifically focusing on its dosage, distribution, and instructions for use. The product is an inhalation powder containing budesonide and lactose, with each actuation delivering 160 mcg of budesonide. It is distributed by Allegis Pharmaceuticals, Inc., for Rubicon Holdings Inc. and licensed by CHEPLAPHARM Arzneimittel GmbH. The medication is trademarked as PULMICORT FLEXHALER by the AstraZeneca group of companies. The text includes guidance for both physicians and patients, emphasizing the importance of consulting the package insert for dosage information and reading the enclosed Patient Information and Instructions for Use thoroughly before use. Additionally, it advises against using the inhaler after the expiration date and provides storage instructions at a controlled room temperature.*